Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study

NCT07159464 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

BIOLOGICAL: CSL312

Sponsor

CSL Behring